drugset / Trial / NCT00717834
Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine
RandomizedParallel-groupOpen-labelPrevention
Summary
The primary objective of this study is to assess the safety and tolerability of the Ross River Virus (RRV) Vaccine in a healthy young adult population. Other objectives of this study are to assess the immunogenicity of the RRV Vaccine in a healthy young adult population and to identify the optimal dose level of the RRV Vaccine in a healthy young adult population.
Timeline
- Start
- 2008-06
- Primary completion
- 2008-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Al(OH)3 | Unknown | — | Intramuscular |
| Subject | Ross River Virus (RRV) Vaccine | Vaccine | 1.25 ug | Intramuscular |
| Subject | Ross River Virus (RRV) Vaccine | Vaccine | 2.5 ug | Intramuscular |
| Subject | Ross River Virus (RRV) Vaccine | Vaccine | 5 ug | Intramuscular |
| Subject | Ross River Virus (RRV) Vaccine | Vaccine | 10 ug | Intramuscular |